Xience V®

DEVICE2 trials

Sponsors

Abbott Medical Devices

Conditions

Coronary Artery DiseaseCoronary Restenosis

Phase 3

Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period

CompletedNCT00882219

Abbott Medical DevicesCoronary Restenosis

Start: 2009-03-31End: 2012-07-31Updated: 2012-09-06

Unknown Phase

Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in France

CompletedNCT00987506

Abbott Medical DevicesCoronary Artery Disease

Start: 2008-06-30End: 2011-12-31Updated: 2012-04-19